NADSYN1-SPAG9 Fusion FISH Probe
The NADSYN1-SPAG9 Fusion FISH Probe is used to confirm a fusion of the NADSYN1 and SPAG9 genes. The fusion of the NADSYN1 and SPAG9 genes has been associated with Esophageal Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NADSYN1-SPAG9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NADSYN1-SPAG9-20-AQAQ | 20 (40 μL) | 200 μL |
|
SPAG9 Gene Summary
This gene encodes a member of the cancer testis antigen gene family. The encoded protein functions as a scaffold protein that structurally organizes mitogen-activated protein kinases and mediates c-Jun-terminal kinase signaling. This protein also binds to kinesin-1 and may be involved in microtubule-based membrane transport. This protein may play a role in tumor growth and development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Gene Name: Sperm Associated Antigen 9
Chromosome: CHR17: 49039534 -49198226
Locus: 17q21.33
NADSYN1 Gene Summary
Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).[supplied by OMIM, Apr 2004]
Gene Name: NAD Synthetase 1
Chromosome: CHR11: 71164216 -71212581
Locus: 11q13.4
Gene Diseases
The NADSYN1 SPAG9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Esophageal Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|